Found: 42
Select item for more details and to access through your institution.
Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag).
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1093/ofid/ofz532
- By:
- Publication type:
- Article
2781. Statistical Modeling to Predict Maternal RSV Vaccine Efficacy from Neutralizing Titers.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S982, doi. 10.1093/ofid/ofz360.2458
- By:
- Publication type:
- Article
2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S970, doi. 10.1093/ofid/ofz360.2432
- By:
- Publication type:
- Article
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 9, p. 2241, doi. 10.1007/s40121-023-00863-5
- By:
- Publication type:
- Article
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, n. 2, p. 141, doi. 10.1093/jpids/piaa035
- By:
- Publication type:
- Article
The impact of human vaccines on bacterial antimicrobial resistance. A review.
- Published in:
- Environmental Chemistry Letters, 2021, v. 19, n. 6, p. 4031, doi. 10.1007/s10311-021-01274-z
- By:
- Publication type:
- Article
A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27316-2
- By:
- Publication type:
- Article
The Interferon Antagonist NS2 Protein of Respiratory Syncytial Virus Is an Important Virulence Determinant for Humans.
- Published in:
- Journal of Infectious Diseases, 2006, v. 193, n. 4, p. 573, doi. 10.1086/499600
- By:
- Publication type:
- Article
Illness Severity, Viral Shedding, and Antibody Responses in Infants Hospitalized with Bronchiolitis Caused by Respiratory Syncytial Virus.
- Published in:
- Journal of Infectious Diseases, 2002, v. 185, n. 8, p. 1011, doi. 10.1086/339822
- By:
- Publication type:
- Article
Correlates of Immune Protection Induced by Live, Attenuated, Cold-Adapted, Trivalent, Intranasal...
- Published in:
- Journal of Infectious Diseases, 2000, v. 181, n. 3, p. 1133, doi. 10.1086/315323
- By:
- Publication type:
- Article
Reduction of Respiratory Syncytial Virus (RSV) in Tracheal Aspirates in Intubated Infants by Use of Humanized Monoclonal Antibody to RSV F Protein.
- Published in:
- Journal of Infectious Diseases, 1998, v. 178, n. 6, p. 1555
- By:
- Publication type:
- Article
Evaluation of Live Attenuated Influenza Vaccines in Children 6–18 Months of Age: Safety, Immunogenicity, and Efficacy.
- Published in:
- Journal of Infectious Diseases, 1996, v. 173, n. 6, p. 1313, doi. 10.1093/infdis/173.6.1313
- By:
- Publication type:
- Article
Topical Immunoprophylaxis of Respiratory Syncytial Virus (RSV)-Challenged Mice with RSV-Specific Immune Globulin.
- Published in:
- Journal of Infectious Diseases, 1995, v. 171, n. 6, p. 1468, doi. 10.1093/infdis/171.6.1468
- By:
- Publication type:
- Article
Comparison of Live Attenuated and Inactivated Influenza Vaccines in Cystic Fibrosis Patients and Their Families: Results of a 3-Year Study.
- Published in:
- Journal of Infectious Diseases, 1994, v. 169, n. 2, p. 241
- By:
- Publication type:
- Article
Comparative Trial of Large-Particle Aerosol and Nose Drop Administration of Live Attenuated Influenza Vaccines.
- Published in:
- Journal of Infectious Diseases, 1993, v. 168, n. 5, p. 1282
- By:
- Publication type:
- Article
Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM<sub>197</sub> conjugate vaccine.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1263, n. 1, p. 15, doi. 10.1111/j.1749-6632.2012.06673.x
- By:
- Publication type:
- Article
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in Mexico.
- Published in:
- Pan American Journal of Public Health, 2013, v. 33, n. 6, p. 414
- By:
- Publication type:
- Article
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIVInfected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 1, p. 18, doi. 10.1093/infdis/jiu631
- By:
- Publication type:
- Article
Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-Nonsusceptible Streptococcus pneumoniae.
- Published in:
- Journal of Infectious Diseases, 2015, v. 211, n. 7, p. 1144, doi. 10.1093/infdis/jiu576
- By:
- Publication type:
- Article
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 3, p. 390, doi. 10.1093/cid/ciab990
- By:
- Publication type:
- Article
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. e1489, doi. 10.1093/cid/ciaa1045
- By:
- Publication type:
- Article
Carrier-Induced Hyporesponsiveness to Pneumococcal Conjugate Vaccines: Unraveling the Influence of Serotypes, Timing, and Previous Vaccine Dose.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 3, p. 448, doi. 10.1093/cid/ciaa083
- By:
- Publication type:
- Article
A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 1, p. 1, doi. 10.1093/cid/ciz153
- By:
- Publication type:
- Article
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 1, p. 42, doi. 10.1093/cid/ciy009
- By:
- Publication type:
- Article
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 5, p. 787, doi. 10.1093/cid/cix419
- By:
- Publication type:
- Article
Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged =2 Years: An Open-Label Study.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 3, p. 313, doi. 10.1093/cid/civ287
- By:
- Publication type:
- Article
Multicenter Surveillance of Streptococcus pneumoniae Isolates From Middle Ear and Mastoid Cultures in the 13-Valent Pneumococcal Conjugate Vaccine Era.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 9, p. 1339, doi. 10.1093/cid/civ067
- By:
- Publication type:
- Article
Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 7, p. 952, doi. 10.1093/cid/cit428
- By:
- Publication type:
- Article
An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine
- Published in:
- BMC Pediatrics, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2431-13-98
- By:
- Publication type:
- Article
An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 5, p. 1194, doi. 10.1093/cid/ciad718
- By:
- Publication type:
- Article
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 5, p. 1360, doi. 10.1093/cid/ciad707
- By:
- Publication type:
- Article
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 2, p. 312, doi. 10.1093/cid/ciad218
- By:
- Publication type:
- Article
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 8, p. 1427, doi. 10.1002/pbc.25502
- By:
- Publication type:
- Article
Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and Revaccination.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 4, p. e905, doi. 10.1093/infdis/jiae185
- By:
- Publication type:
- Article
A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses of a Clostridioides difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 2, p. 367, doi. 10.1093/infdis/jiad307
- By:
- Publication type:
- Article
Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 12, p. 2054, doi. 10.1093/infdis/jiac189
- By:
- Publication type:
- Article
Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 12, p. 2056, doi. 10.1093/infdis/jiab611
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 12, p. 2077, doi. 10.1093/infdis/jiab505
- By:
- Publication type:
- Article
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in Mexico.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in Mexico.
- Published in:
- Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2013, v. 33, n. 6, p. 414
- By:
- Publication type:
- Article